Sign up to save your podcasts
Or
Share Expert Insights Into the Biosafety of Oncolytic Immunotherapies and Their Combination With Immune Checkpoint Inhibitors
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Expert Insights Into the Biosafety of Oncolytic Immunotherapies and Their Combination With Immune Checkpoint Inhibitors
Do you know how the biosafety risks of oncolytic immunotherapies and their combination with immune checkpoint inhibitors can be mitigated?
Credit available for this activity expires: 6/22/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/993479?ecd=bdc_podcast_libsyn_mscpedu
View all episodes
By Medscape
4.2
2222 ratings
Do you know how the biosafety risks of oncolytic immunotherapies and their combination with immune checkpoint inhibitors can be mitigated?
Credit available for this activity expires: 6/22/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/993479?ecd=bdc_podcast_libsyn_mscpedu
More shows like Keeping Current CME
View all
JAMA Editors' Summary
127 Listeners
Medicine and Science from The BMJ
38 Listeners
The Bob Harrington Show
13 Listeners
NEJM This Week
315 Listeners
This Week in Cardiology
853 Listeners
JAMA Clinical Reviews
478 Listeners
AFP: American Family Physician Podcast
688 Listeners
One-on-One with Eric Topol
16 Listeners
Mayo Clinic Talks
273 Listeners
Frankly Speaking About Family Medicine
251 Listeners
The Curbsiders Internal Medicine Podcast
3,321 Listeners
JAMA Medical News
91 Listeners
Core IM | Internal Medicine Podcast
1,085 Listeners
Annals On Call Podcast
175 Listeners
The Clinical Problem Solvers
513 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
318 Listeners
Medicine and the Machine
59 Listeners
Keeping Current
8 Listeners
Run the List
245 Listeners
The Curious Clinicians
364 Listeners